Article Details
Retrieved on: 2021-01-13 22:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... another therapy, anti-PD1 monoclonal antibodies. Aivita also plans to seek commercial approval in Japan for its melanoma immunotherapy through ...
Article found on: medcitynews.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here